OLMA (Olema Pharmaceuticals) ROE % Adjusted to Book Value: -16.34% (As of Mar. 2026)


OLMA Olema Pharmaceuticals inc OLMA
33 GF Score
Price $11.20
! 2 Warning Signs
View Full Analysis

What is Olema Pharmaceuticals ROE % Adjusted to Book Value?

Olema Pharmaceuticals OLMA +0.54% 33 ROE % Adjusted to Book Value is -16.34% as of Mar. 2026. GuruFocus rates OLMA with a GF Score™ of 33/100. The stock has 2 warning signs investors should review.

Olema Pharmaceuticals's ROE % for the quarter that ended in Mar. 2026 was -44.29%. Olema Pharmaceuticals's PB Ratio for the quarter that ended in Mar. 2026 was 2.71. Olema Pharmaceuticals's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2026 was -16.34%.

Olema Pharmaceuticals ROE % Adjusted to Book Value Related Terms

Olema Pharmaceuticals ROE % Adjusted to Book Value Historical Data

* Premium members only.

The historical data trend for Olema Pharmaceuticals's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Olema Pharmaceuticals ROE % Adjusted to Book Value Chart

Olema Pharmaceuticals Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROE % Adjusted to Book Value
Get a 7-Day Free Trial -17.43 -86.94 -14.09 -36.86 -8.61

Olema Pharmaceuticals Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -45.79 -56.55 -23.63 -11.03 -16.34

OLMA vs AKTS, ZBIO, MNKD: ROE % Adjusted to Book Value Comparison

For the Biotechnology subindustry, Olema Pharmaceuticals's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Olema Pharmaceuticals ROE % Adjusted to Book Value vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Olema Pharmaceuticals's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Olema Pharmaceuticals's ROE % Adjusted to Book Value falls into.


OLMA
33GF Score
Olema Pharmaceuticals inc OLMA
ROE % Adjusted to Book Value is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Olema Pharmaceuticals ROE % Adjusted to Book Value Calculation

Olema Pharmaceuticals's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2025 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-36.61% / 4.25
=-8.61%

Olema Pharmaceuticals's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2026 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-44.29% / 2.71
=-16.34%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROE % Adjusted to Book Value of -16.34% mean?
Olema Pharmaceuticals (OLMA) has a ROE % Adjusted to Book Value of -16.34% as of Mar. 2026. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Olema Pharmaceuticals and its competitors.
Is Olema Pharmaceuticals' ROE % Adjusted to Book Value too high?
Olema Pharmaceuticals' current ROE % Adjusted to Book Value is -16.34%. Overall, Olema Pharmaceuticals has a GF Score™ of 33/100, reflecting its overall financial health beyond just this single metric.
How does Olema Pharmaceuticals' ROE % Adjusted to Book Value compare to AKTS and ZBIO?
Olema Pharmaceuticals' ROE % Adjusted to Book Value of -16.34% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Biotechnology company?
A good ROE % Adjusted to Book Value depends on the Biotechnology industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Olema Pharmaceuticals and its competitors. Olema Pharmaceuticals's current ROE % Adjusted to Book Value is -16.34%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Olema Pharmaceuticals stock overvalued right now?
Olema Pharmaceuticals (OLMA) has a current ROE % Adjusted to Book Value of -16.34%. The current ROE % Adjusted to Book Value is -16.34%. Olema Pharmaceuticals' overall GF Score™ is 33/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For Olema Pharmaceuticals (OLMA), the current ROE % Adjusted to Book Value is -16.34% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Olema Pharmaceuticals Business Description

Address 780 Brannan Street, San Francisco, CA, USA, 94103
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.
33GF Score

Get the complete analysis for OLMA

ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$11.20
Price